Picture of Seelos Therapeutics logo

SEELQ — Seelos Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Seelos Is Temporarily Pausing Additional Enrollment Of Patients In SLS-005-302 Study

March 29 (Reuters) - Seelos Therapeutics Inc  SEEL.O :
    * SEELOS THERAPEUTICS ANNOUNCES BUSINESS UPDATE ON ITS KEY
PROGRAMS
    * SEELOS THERAPEUTICS INC- IS TEMPORARILY PAUSING ADDITIONAL
ENROLLMENT OF PATIENTS IN SLS-005-302 STUDY IN SPINOCEREBELLAR
ATAXIA TYPE 3 (SCA3)

Source text for Eikon:  ID:nPnbd5xbha 
Further company coverage:  SEEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Seelos Therapeutics

See all news